COM_RESEARCHSTUDIES_DETAIL_AVAL_STATUS_4

LCCC 1739: Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer

The purpose of the study is to better understand how pembrolizumab may work to help your immune system fight your cancer.

Age & Gender

18 years ~ 99 years
Female

Contact the Team

Location

COM_RESEARCHSTUDIES_DETAIL_HEADER_BASIC_CONTACT_4

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Victoria Bae-Jump
LCCC - Clinical Trials

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Uterine (endometrial))

IRB Number

18-2384

ClinicalTrials.gov

NCT03694834

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

My UNC Chart
Find a Doctor
Accessibility
Privacy Policy
For Researchers

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.